NantKwest Announces Presentation of Positive Phase 2 Clinical Data of Natural Killer Cell Therapy in Metastatic Merkel Cell Carcinoma at SITC 2019

Stock Information for NantKwest Inc.

Loading

Please wait while we load your information from QuoteMedia.